Food and Drug Administration leaders blocked peer-reviewed release of research affirming that Covid-19 and shingles inoculations carried minimal danger, despite analyses of millions of patient files funded by public money. Scientists prepared findings for medical journals and conferences before senior appointees intervened. Career staff complied while questioning claims that broad conclusions outran underlying evidence, leaving rigorous work unpublished.

Millions of dollars in contracts paid data firms to mine records covering 7.5 million Medicare beneficiaries and 4.2 million younger adults, identifying rare but known reactions such as anaphylaxis, myocarditis and fever-related seizures without detecting widespread harms. Shingrix abstracts went unsigned in February after October saw two Covid vaccine studies withdrawn from Drug Safety, erasing avenues for independent scrutiny of federally financed safety assessments.

Suppression extends beyond F.D.A. walls, with Health and Human Services leadership demanding deletion of thimerosal summaries and retraction demands aimed at Danish aluminum-salts research while a Centers for Disease Control and Prevention hospitalization report also vanished. Censorship claims now shadow agencies once trusted to vet products, revealing how political directives can eclipse documented evidence and leave investors uncertain about regulatory reliability.